Predicting outcome in patients with anti-GBM glomerulonephritis

Publication date

2018-01-06

Authors

van Daalen, Emma
Jennette, J. Charles
McAdoo, Stephen P.
Pusey, Charles D.
Alba, Marco A.
Poulton, Caroline J.
Wolterbeek, Ron
Nguyen, Tri QISNI 0000000394141746
Goldschmeding, RoelISNI 0000000389519863
Alchi, Bassam

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

Background and objectives Large studies on long-term kidney outcome in patients with anti-glomerular basement membrane (anti-GBM) GN are lacking. This study aimed to identify clinical and histopathologic parameters that predict kidney outcome in these patients. Design, setting, participants, &measurements This retrospective analysis included a total of 123 patients with anti-GBM GN between 1986 and 2015 from six centers worldwide. Their kidney biopsy samples were classified according to the histopathologic classification for ANCA-associated GN. Clinical data such as details of treatment were retrieved from clinical records. The primary outcome parameter was the occurrence of ESRD. Kidney survival was analyzed using the log-rank test and Cox regression analyses. Results The 5-year kidney survival rate was 34%, with an improved rate observed among patients diagnosed after 2007 (P=0.01). In patients with anti-GBM GN, histopathologic class and kidney survival were associated (P˂ 0.001). Only one of 15 patients with a focal class biopsy sample (≥50% normal glomeruli) developed ESRD. Patients with a sclerotic class biopsy sample (≥50% globally sclerotic glomeruli) and patients with 100% cellular crescents did not recover from dialysis dependency at presentation. Inmultivariable analysis, dialysis dependency at presentation (hazard ratio [HR], 3.17; 95% confidence interval [95% CI], 1.59 to 6.32), percentage of normal glomeruli (HR, 0.97; 95% CI, 0.95 to 0.99), and extent of interstitial infiltrate (HR, 2.02; 95% CI, 1.17 to 3.50) were predictors of ESRD during follow-up. Conclusions Dialysis dependency, low percentage of normal glomeruli, and large extent of interstitial infiltrate are associated with poor kidney outcome in anti-GBM GN. Kidney outcome has improved during recent years; the success rate doubled after 2007.

Keywords

ANCA, Anti-GBM disease, Antibodies antineutrophil, Antiglomerular basement membrane antibody, Autoantibodies, Biopsy, Confidence intervals, Cytoplasmic, Follow-Up studies, Glomerular basement membrane, Glomerulonephritis, Goodpasture-s syndrome, Kidney, Kidney biopsy, Kidney failure chronic, Multivariate analysis, Regression analysis, Renal dialysis, Retrospective studies, Survival rate, Taverne, Epidemiology, Critical Care and Intensive Care Medicine, Nephrology, Transplantation

Citation

van Daalen, E, Jennette, J C, McAdoo, S P, Pusey, C D, Alba, M A, Poulton, C J, Wolterbeek, R, Nguyen, T Q, Goldschmeding, R, Alchi, B, Griffiths, M, de Zoysa, J R, Vincent, B, Bruijn, J A & Bajema, I M 2018, 'Predicting outcome in patients with anti-GBM glomerulonephritis', Clinical Journal of the American Society of Nephrology, vol. 13, no. 1, pp. 63-72. https://doi.org/10.2215/CJN.04290417